Details of Drug

Drug General Information (ID: D0636)
Drug Name	Famotidine
Drug Type	Small molecule
Drug Synonymous	Pepcid; famotidine; 76824-35-6; Pepcid AC; Pepcidine; Quamatel; Gastridin; Famodil; Dispromil; Pepdine; Digervin; Gaster; Fluxid; Pepdul; Pepcid RPD; Famulcer; Supertidine; Pepcidina; Fagastine; Whitidin; Farmotex; Peptifam; Ferotine; Dispronil; Tairal; Sigafam; Famtac; Durater; Yamarin; Pepzan; Famoxal; Evatin; Weimok; Pepdif; Fudone; Fanosin; Fanobel; Duovel; Fibonel; Fadine; Dipsin; Ganor; Fadin; Dinul; Fanox; Fadyn; Famox; Famo; Nu-Famotidine; Pepcidin Rapitab; Sedanium-R; Dibrit 40; Famotidinum [Latin]; PEPCID; Famotidina [Spanish]; Apogastine; Antodine; Bestidine; Amfamox; Blocacid; Brolin; Cepal; Confobos; Cronol; Cuantin; Famocid; Famodar; Famodin; Famodine; Famogard; Famonit; Famopsin; Famos; Famosan; Famotal; Famotep; Famotin; Famovane; Famowal; Gastridan; Gastrion; Gastro; Gastrodomina; Gastrofam; Gastropen; Gastrosidin; Hacip; Huberdina; Ingastri; Invigan; Lecedil; Logos; Mensoma; Midefam; Mosul; Motiax; Muclox; Neocidine; Nevofam; Notidin; Nulceran; Nulcerin; Panalba; Pepcidac; Pepcidin; Pepfamin; Peptan; Peptidin; Purifam; Quamtel; Renapepsa; Restadin; Rogasti; Rubacina; Tamin; Tipodex; Topcid; Ulcatif; Ulceprax; Ulcofam; Ulfagel; Ulfam; Ulfamid; Ulfinol; Ulgarine; Vagostal; FAMOTIDINE PRESERVATIVE FREE; FAMOTIDINE PRESERVATIVE FREE IN PLASTIC CONTAINER; Mylanta AR; PEPCID COMPLETE; PEPCID PRESERVATIVE FREE; PEPCID PRESERVATIVE FREE IN PLASTIC CONTAINER; Pepcid AC Gelcaps; PepcidRPD; F 6889; F0530; L 643341; MK 208; YM 11170; Apo-Famotidine; HS-0054; MK-208; Novo-Famotidine; Pepcid (TN); Pepcidine (TN); YM-11170; YM-1170; Famotidine [USAN:BAN:INN:JAN]; Propanimidamide, 3-[[[2-[aminoiminomethyl)amino]-4-thiazoyl]methyl]thio]-N-(aminosulfonyl); N'-(Aminosulfonyl)-3-([2-(diaminomethyleneamino)-4-thiazolyl]methylthio)propanamidine; (1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamide; (1Z)-3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)sulfanyl]-N'-sulfamoylpropanimidamide; (1Z)-N'-(aminosulfonyl)-3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)thio]propanimidamide; 3-(2-Guanidinothiazol-4-ylmethylthio)-N1-sulfamoylpropionamide; 3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)sulfanyl]-N-sulfamoylpropanimidamide; 3-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]-N'-sulfamoylpro; 3-[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methylsulfanyl]-N'-sulfamoylpropanimidamide Click to Show/Hide
Disease Class	DA61: Peptic ulcer
Therapeutic Class	Antiulcer Agents
Structure
Structure	3D Structure		2D Structure
Formula	C8H15N7O2S3
InChI	1S/C8H15N7O2S3/c9-6(15-20(12,16)17)1-2-18-3-5-4-19-8(13-5)14-7(10)11/h4H,1-3H2,(H2,9,15)(H2,12,16,17)(H4,10,11,13,14)
InChIKey	XUFQPHANEAPEMJ-UHFFFAOYSA-N
Canonical SMILES	C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
External Link
	Pubchem ID	5702160
	CAS Number	76824-35-6
	CHEBI ID	4975
	TTD ID	D0K0OZ
	INTEDE ID	DR0680
	VARIDT ID	DR00278

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM001 Affected gastrointestinal absorption AM004 Affected intra/extra-hepatic metabolism AM005 Affected excretion pathways AM006 Pharmacodynamic additive effects BM005 Altered gastric pH BM017 CYP450 enzyme inhibition BM028 Competitive inhibition of renal tubular secretion BM049 Increased risk of atrioventricular block BM051 Increased risk of bradycardia BM076 Increased risk of prolong QT interval BM081 Increased risk of ventricular arrhythmias
Relation Graph

Full list of drugs interacting with Famotidine
Affected gastrointestinal absorption
	Altered gastric pH					Drug Num: 50
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0116		Atazanavir	C38H52N6O7	148192	Major		Inter Info	[1], [2], [3], [4], [5], [6], [7], [8]
D0428		Dasatinib	C22H26ClN7O2S	3062316	Major		Inter Info	[9]
D1124		Neratinib	C30H29ClN6O3	9915743	Major		Inter Info	[10], [11]
D1232		Pazopanib	C21H23N7O2S	10113978	Major		Inter Info	[1], [13], [14], [15], [16], [17]
D1404		Rilpivirine	C22H18N6	6451164	Major		Inter Info	[18]
D1459		Selpercatinib	C29H31N7O3	134436906	Major		Inter Info	[1], [19]
D0013		Acetohexamide	C15H20N2O4S	1989	Moderate		Inter Info	[30], [31], [32], [33]
D0325		Chlorpropamide	C10H13ClN2O3S	2727	Moderate		Inter Info	[30], [31], [32], [33]
D0439		Delavirdine	C22H28N6O3S	5625	Moderate		Inter Info	[43]
D0595		Erlotinib	C22H23N3O4	176870	Moderate		Inter Info	[10], [1], [48], [49]
D0008		Acalabrutinib	C26H23N7O2	71226662	Moderate		Inter Info	[50]
D0141		Bacampicillin	C21H27N3O7S	441397	Moderate		Inter Info	[80], [81]
D0195		Bosutinib	C26H29Cl2N5O3	5328940	Moderate		Inter Info	[1], [82]
D0278		Cefditoren	C19H18N6O5S3	9870843	Moderate		Inter Info	[84]
D0288		Cefpodoxime	C15H17N5O6S2	6335986	Moderate		Inter Info	[80], [85], [86], [81]
D0297		Cefuroxime	C16H16N4O8S	5479529	Moderate		Inter Info	[80], [85], [86], [81]
D0302		Ceritinib	C28H36ClN5O3S	57379345	Moderate		Inter Info	[87]
D0406		Dabrafenib	C23H20F3N5O2S2	44462760	Moderate		Inter Info	[10], [1], [88], [89], [90], [91], [92]
D0409		Dacomitinib	C24H25ClFN5O2	11511120	Moderate		Inter Info	[1], [93]
D0692		Fosamprenavir	C25H36N3O9PS	131536	Moderate		Inter Info	[96]
D0728		Glipizide	C21H27N5O4S	3478	Moderate		Inter Info	[30], [31], [32], [33]
D0730		Glyburide	C23H28ClN3O5S	3488	Moderate		Inter Info	[30], [31], [32], [33]
D0867		Itraconazole	C35H38Cl2N8O4	55283	Moderate		Inter Info	[97], [98], [99], [100]
D0880		Ketoconazole	C26H28Cl2N4O4	456201	Moderate		Inter Info	[102], [97], [103], [104], [105], [1], [106], [107], [108], [109]
D0894		Lapatinib	C29H26ClFN4O4S	208908	Moderate		Inter Info	[1], [110]
D0898		Ledipasvir	C49H54F2N8O6	67505836	Moderate		Inter Info	[112]
D1136		Nilotinib	C28H22F3N7O	644241	Moderate		Inter Info	[10], [1], [113]
D1258		Pexidartinib	C20H15ClF3N5	25151352	Moderate		Inter Info	[114]
D1315		Posaconazole	C37H42F2N8O4	468595	Moderate		Inter Info	[115], [34], [116], [117], [118], [119], [120], [121], [122], [123], [124]
D1603		Tolbutamide	C12H18N2O3S	5505	Moderate		Inter Info	[30], [31], [32], [33]
D1686		Velpatasvir	C49H54N8O8	67683363	Moderate		Inter Info	[127]
D0713		Gefitinib	C22H24ClFN4O3	123631	Moderate		Inter Info	[128]
D0727		Glimepiride	C24H34N4O5S	3476	Moderate		Inter Info	[30], [31], [32], [33]
D1601		Tolazamide	C14H21N3O3S	5503	Moderate		Inter Info	[30], [31], [32], [33]
D0395		Cyanocobalamin	C63H88CoN14O14P	5311498	Minor		Inter Info	[130], [131], [132], [133], [134]
D0539		Duloxetine	C18H19NOS	60835	Minor		Inter Info	[135]
D0573		Enoxacin	C15H17FN4O3	3229	Minor		Inter Info	[136], [137]
D0049		Aluminum hydroxide	AlH3O3	10176082	Minor		Inter Info	[138], [139], [52], [140], [141], [142], [143], [144], [145], [146], [147], [148]
D0133		Axitinib	C22H18N4OS	6450551	Minor		Inter Info	[149]
D0236		Calcium carbonate	CCaO3	10112	Minor		Inter Info	[138], [139], [52], [140], [141], [142], [143], [144], [145], [146], [147], [148]
D0967		Magaldrate	AlHMgO5S+2	3086011	Minor		Inter Info	[138], [139], [52], [140], [141], [142], [143], [144], [145], [146], [147], [148]
D0968		Magnesium carbonate	CMgO3	11029	Minor		Inter Info	[138], [139], [52], [140], [141], [142], [143], [144], [145], [146], [147], [148]
D0973		Magnesium hydroxide	H2MgO2	14791	Minor		Inter Info	[138], [139], [52], [140], [141], [142], [143], [144], [145], [146], [147], [148]
D0974		Magnesium oxide	MgO	14792	Minor		Inter Info	[138], [139], [52], [140], [141], [142], [143], [144], [145], [146], [147], [148]
D0989		Mecobalamin	C63H91CoN13O14P	10898559	Minor		Inter Info	[131], [132], [134]
D1313		Ponatinib	C29H27F3N6O	24826799	Minor		Inter Info	[10], [150]
D1328		Prasugrel	C20H20FNO3S	6918456	Minor		Inter Info	[151], [152]
D1377		Raltegravir	C20H21FN6O5	54671008	Minor		Inter Info	[154]
D1480		Sodium bicarbonate	CHNaO3	516892	Minor		Inter Info	[138], [139], [52], [140], [141], [142], [143], [144], [145], [146], [147], [148]
D1701		Vismodegib	C19H14Cl2N2O3S	24776445	Minor		Inter Info	[10], [1], [159]
Affected intra/extra-hepatic metabolism
	CYP450 enzyme inhibition					Drug Num: 5
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1596		Tizanidine	C9H8ClN5S	5487	Major		Inter Info	[21], [22], [23], [24], [25], [26], [27], [28]
D0064		Aminophylline	C16H24N10O4	9433	Moderate		Inter Info	[51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79]
D1201		Oxtriphylline	C12H21N5O3	656652	Moderate		Inter Info	[51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79]
D1378		Ramelteon	C16H21NO2	208902	Moderate		Inter Info	[125]
D1570		Theophylline	C7H8N4O2	2153	Moderate		Inter Info	[51], [52], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72], [73], [74], [75], [76], [77], [78], [79]
Affected excretion pathways
	Competitive inhibition of renal tubular secretion					Drug Num: 3
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0576		Entecavir	C12H15N5O3	135398508	Moderate		Inter Info	[47]
D1241		Pemetrexed	C20H21N5O6	135410875	Moderate		Inter Info	[129]
D1341		Probenecid	C13H19NO4S	4911	Minor		Inter Info	[153]
Pharmacodynamic additive effects
	Increased risk of bradycardia					Drug Num: 5
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1474		Siponimod	C29H35F3N2O3	44599207	Major		Inter Info	[10], [20]
D0204		Brigatinib	C29H39ClN7O2P	68165256	Moderate		Inter Info	[83]
D0661		Fingolimod	C19H33NO2	107970	Moderate		Inter Info	[94], [95]
D0868		Ivabradine	C27H36N2O5	132999	Moderate		Inter Info	[10], [101]
D0897		Lasmiditan	C19H18F3N3O2	11610526	Moderate		Inter Info	[111]
	Increased risk of prolong QT interval					Drug Num: 165
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0003		Abarelix	C72H95ClN14O14	16131215	Moderate		Inter Info	[10], [1], [29]
D0036		Alfuzosin	C19H27N5O4	2092	Moderate		Inter Info	[10], [1], [29]
D0068		Amitriptyline	C20H23N	2160	Moderate		Inter Info	[10], [1], [29]
D0072		Amoxapine	C17H16ClN3O	2170	Moderate		Inter Info	[10], [1], [29]
D0084		Anagrelide	C10H7Cl2N3O	135409400	Moderate		Inter Info	[10], [1], [29]
D0097		Apomorphine	C17H17NO2	6005	Moderate		Inter Info	[10], [1], [29]
D0115		Astemizole	C28H31FN4O	2247	Moderate		Inter Info	[10], [1], [29]
D0219		Buprenorphine	C29H41NO4	644073	Moderate		Inter Info	[10], [1], [29]
D0320		Chloroquine	C18H26ClN3	2719	Moderate		Inter Info	[10], [1], [29]
D0324		Chlorpromazine	C17H19ClN2S	2726	Moderate		Inter Info	[10], [1], [29]
D0341		Ciprofloxacin	C17H18FN3O3	2764	Moderate		Inter Info	[10], [1], [29]
D0342		Cisapride	C23H29ClFN3O4	6917698	Moderate		Inter Info	[10], [1], [29]
D0345		Citalopram	C20H21FN2O	2771	Moderate		Inter Info	[10], [1], [29]
D0358		Clofazimine	C27H22Cl2N4	2794	Moderate		Inter Info	[10], [1], [29]
D0370		Clozapine	C18H19ClN4	135398737	Moderate		Inter Info	[10], [1], [29]
D0429		Daunorubicin	C27H29NO10	30323	Moderate		Inter Info	[10], [1], [29]
D0430		Daunorubicin (liposomal)	C27H29NO10	30323	Moderate		Inter Info	[10], [1], [42]
D0467		Dextropropoxyphene	C22H29NO2	10100	Moderate		Inter Info	[10], [1], [42]
D0508		Disopyramide	C21H29N3O	3114	Moderate		Inter Info	[10], [1], [29]
D0513		Dofetilide	C19H27N3O5S2	71329	Moderate		Inter Info	[10], [1], [29]
D0514		Dolasetron	C19H20N2O3	3033818	Moderate		Inter Info	[10], [1], [29]
D0535		Droperidol	C22H22FN3O2	3168	Moderate		Inter Info	[10], [1], [29]
D0554		Efavirenz	C14H9ClF3NO2	64139	Moderate		Inter Info	[10], [1], [29]
D0584		Epirubicin	C27H29NO11	41867	Moderate		Inter Info	[10], [1], [29]
D0597		Erythromycin	C37H67NO13	12560	Moderate		Inter Info	[10], [1], [29]
D0007		Abiraterone	C24H31NO	132971	Moderate		Inter Info	[10], [1], [29]
D0037		Alimemazine	C18H22N2S	5574	Moderate		Inter Info	[10], [1], [42]
D0066		Amiodarone	C25H29I2NO3	2157	Moderate		Inter Info	[10], [1], [29]
D0067		Amisulpride	C17H27N3O4S	2159	Moderate		Inter Info	[10], [1], [29]
D0103		Arformoterol	C19H24N2O4	3083544	Moderate		Inter Info	[10], [1], [29]
D0105		Aripiprazole	C23H27Cl2N3O2	60795	Moderate		Inter Info	[10], [1], [29]
D0107		Arsenic trioxide	As2O3	14888	Moderate		Inter Info	[10], [1], [29]
D0112		Asenapine	C17H16ClNO	3036780	Moderate		Inter Info	[10], [1], [29]
D0149		Bedaquiline	C32H31BrN2O2	5388906	Moderate		Inter Info	[10], [1], [29]
D0170		Bepridil	C24H34N2O	2351	Moderate		Inter Info	[10], [1], [29]
D0180		Bicalutamide	C18H14F4N2O4S	2375	Moderate		Inter Info	[10], [1], [29]
D0336		Cilostazol	C20H27N5O2	2754	Moderate		Inter Info	[10], [1], [29]
D0361		Clomipramine	C19H23ClN2	2801	Moderate		Inter Info	[10], [1], [29]
D0393		Crizotinib	C21H22Cl2FN5O	11626560	Moderate		Inter Info	[10], [1], [29]
D0437		Degarelix	C82H103ClN18O16	16136245	Moderate		Inter Info	[10], [1], [29]
D0446		Desipramine	C18H22N2	2995	Moderate		Inter Info	[10], [1], [29]
D0452		Deutetrabenazine	C19H27NO3	73437646	Moderate		Inter Info	[10], [1], [29]
D0525		Doxepin	C19H21NO	667477	Moderate		Inter Info	[10], [1], [29]
D0526		Doxepin (topical)	C19H21NO	667477	Moderate		Inter Info	[10], [1], [42]
D0528		Doxorubicin	C27H29NO11	31703	Moderate		Inter Info	[10], [1], [29]
D0529		Doxorubicin (liposomal)	C27H29NO11	31703	Moderate		Inter Info	[10], [1], [42]
D0534		Dronedarone	C31H44N2O5S	208898	Moderate		Inter Info	[10], [1], [29]
D0569		Encorafenib	C22H27ClFN7O4S	50922675	Moderate		Inter Info	[10], [1], [29]
D0577		Entrectinib	C31H34F2N6O2	25141092	Moderate		Inter Info	[10], [1], [29]
D0578		Enzalutamide	C21H16F4N4O2S	15951529	Moderate		Inter Info	[10], [1], [29]
D0594		Eribulin	C40H59NO11	11354606	Moderate		Inter Info	[10], [1], [29]
D0664		Flecainide	C17H20F6N2O3	3356	Moderate		Inter Info	[10], [1], [29]
D0691		Formoterol	C19H24N2O4	3410	Moderate		Inter Info	[10], [1], [29]
D0700		Fostemsavir	C25H26N7O8P	11319217	Moderate		Inter Info	[10], [1], [29]
D0712		Gatifloxacin	C19H22FN3O4	5379	Moderate		Inter Info	[10], [1], [29]
D0716		Gemifloxacin	C18H20FN5O4	9571107	Moderate		Inter Info	[10], [1], [29]
D0720		Gilteritinib	C29H44N8O3	49803313	Moderate		Inter Info	[10], [1], [29]
D0725		Glasdegib	C21H22N6O	25166913	Moderate		Inter Info	[10], [1], [29]
D0749		Halofantrine	C26H30Cl2F3NO	37393	Moderate		Inter Info	[10], [1], [29]
D0751		Halothane	C2HBrClF3	3562	Moderate		Inter Info	[10], [1], [29]
D0758		Histrelin	C66H86N18O12	25077993	Moderate		Inter Info	[10], [1], [29]
D0779		Hydroxychloroquine	C18H26ClN3O	3652	Moderate		Inter Info	[10], [1], [29]
D0788		Idarubicin	C26H27NO9	42890	Moderate		Inter Info	[10], [1], [29]
D0791		Iloperidone	C24H27FN2O4	71360	Moderate		Inter Info	[10], [1], [29]
D0806		Inotuzumab ozogamicin	NA	NA	Moderate		Inter Info	[10], [1], [29]
D0859		Isoprenaline	C11H17NO3	3779	Moderate		Inter Info	[10], [1], [42]
D0872		Ivosidenib	C28H22ClF3N6O3	71657455	Moderate		Inter Info	[10], [1], [29]
D0899		Lefamulin	C28H45NO5S	25185057	Moderate		Inter Info	[10], [1], [29]
D0903		Lenvatinib	C21H19ClN4O4	9823820	Moderate		Inter Info	[10], [1], [29]
D0919		Levofloxacin	C18H20FN3O4	149096	Moderate		Inter Info	[10], [1], [29]
D0924		Levosalbutamol	C13H21NO3	123600	Moderate		Inter Info	[10], [1], [42]
D0937		Lisdexamfetamine	C15H25N3O	11597698	Moderate		Inter Info	[10], [1], [29]
D0940		Lithium carbonate	CLi2O3	11125	Moderate		Inter Info	[10], [1], [42]
D0942		Lofexidine	C11H12Cl2N2O	30668	Moderate		Inter Info	[10], [1], [29]
D0943		Lomefloxacin	C17H19F2N3O3	3948	Moderate		Inter Info	[10], [1], [29]
D0948		Lopinavir	C37H48N4O5	92727	Moderate		Inter Info	[10], [1], [42]
D0960		Lumefantrine	C30H32Cl3NO	6437380	Moderate		Inter Info	[10], [1], [42]
D0979		Maprotiline	C20H23N	4011	Moderate		Inter Info	[10], [1], [29]
D1010		Mesoridazine	C21H26N2OS2	4078	Moderate		Inter Info	[10], [1], [29]
D1026		Methotrimeprazine	C19H24N2OS	72287	Moderate		Inter Info	[10], [1], [29]
D1062		Midostaurin	C35H30N4O4	9829523	Moderate		Inter Info	[10], [1], [29]
D1155		Norfloxacin	C16H18FN3O3	4539	Moderate		Inter Info	[10], [1], [29]
D1165		Ofloxacin	C18H20FN3O4	4583	Moderate		Inter Info	[10], [1], [29]
D1169		Oliceridine	C22H30N2O2S	66553195	Moderate		Inter Info	[10], [1], [29]
D1189		Osilodrostat	C13H10FN3	44139752	Moderate		Inter Info	[10], [1], [29]
D1190		Osimertinib	C28H33N7O2	71496458	Moderate		Inter Info	[10], [1], [29]
D1215		Paliperidone	C23H27FN4O3	115237	Moderate		Inter Info	[10], [1], [29]
D1221		Panobinostat	C21H23N3O2	6918837	Moderate		Inter Info	[10], [1], [29]
D1230		Pasireotide	C58H66N10O9	9941444	Moderate		Inter Info	[10], [1], [29]
D1290		Pimavanserin	C25H34FN3O2	10071196	Moderate		Inter Info	[10], [1], [29]
D1292		Pimozide	C28H29F2N3O	16362	Moderate		Inter Info	[10], [1], [29]
D1298		Pirbuterol	C12H20N2O3	4845	Moderate		Inter Info	[10], [1], [29]
D1302		Pitolisant	C17H26ClNO	9948102	Moderate		Inter Info	[10], [1], [29]
D1339		Primaquine	C15H21N3O	4908	Moderate		Inter Info	[10], [1], [29]
D1342		Probucol	C31H48O2S2	4912	Moderate		Inter Info	[10], [1], [29]
D1343		Procainamide	C13H21N3O	4913	Moderate		Inter Info	[10], [1], [29]
D1352		Promethazine	C17H20N2S	4927	Moderate		Inter Info	[10], [1], [29]
D1353		Propafenone	C21H27NO3	4932	Moderate		Inter Info	[10], [1], [29]
D1388		Relugolix	C29H27F2N7O5S	10348973	Moderate		Inter Info	[10], [1], [29]
D1398		Ribociclib	C23H30N8O	44631912	Moderate		Inter Info	[10], [1], [29]
D1424		Romidepsin	C24H36N4O6S2	5352062	Moderate		Inter Info	[10], [1], [29]
D1432		Rucaparib	C19H18FN3O	9931954	Moderate		Inter Info	[10], [1], [29]
D1438		Salbutamol	C13H21NO3	2083	Moderate		Inter Info	[10], [1], [42]
D1440		Salmeterol	C25H37NO4	5152	Moderate		Inter Info	[10], [1], [29]
D1444		Saquinavir	C38H50N6O5	441243	Moderate		Inter Info	[10], [1], [29]
D1463		Sevoflurane	C4H3F7O	5206	Moderate		Inter Info	[10], [1], [29]
D1491		Solifenacin	C23H26N2O2	154059	Moderate		Inter Info	[10], [1], [29]
D1522		Sunitinib	C22H27FN4O2	5329102	Moderate		Inter Info	[10], [1], [29]
D1542		Telavancin	C80H106Cl2N11O27P	3081362	Moderate		Inter Info	[10], [1], [29]
D1560		Tetrabenazine	C19H27NO3	6018	Moderate		Inter Info	[10], [1], [29]
D1634		Triclabendazole	C14H9Cl3N2OS	50248	Moderate		Inter Info	[10], [1], [29]
D1651		Triptorelin	C64H82N18O13	25074470	Moderate		Inter Info	[10], [1], [29]
D1673		Valbenazine	C24H38N2O4	24795069	Moderate		Inter Info	[10], [1], [29]
D1681		Vandetanib	C22H24BrFN4O2	3081361	Moderate		Inter Info	[10], [1], [29]
D1687		Vemurafenib	C23H18ClF2N3O3S	42611257	Moderate		Inter Info	[10], [1], [29]
D1695		Vilanterol	C24H33Cl2NO5	10184665	Moderate		Inter Info	[10], [1], [42]
D0667		Fluconazole	C13H12F2N6O	3365	Moderate		Inter Info	[10], [1], [29]
D0682		Flutamide	C11H11F3N2O3	3397	Moderate		Inter Info	[10], [1], [29]
D0694		Foscarnet	CH3O5P	3415	Moderate		Inter Info	[10], [1], [29]
D0737		Goserelin	C59H84N18O14	5311128	Moderate		Inter Info	[10], [1], [29]
D0738		Granisetron	C18H24N4O	5284566	Moderate		Inter Info	[10], [1], [29]
D0740		Grepafloxacin	C19H22FN3O3	72474	Moderate		Inter Info	[10], [1], [29]
D0750		Haloperidol	C21H23ClFNO2	3559	Moderate		Inter Info	[10], [1], [29]
D0781		Hydroxyzine	C21H27ClN2O2	3658	Moderate		Inter Info	[10], [1], [29]
D0795		Imipramine	C19H24N2	3696	Moderate		Inter Info	[10], [1], [29]
D0854		Isoetharine	C13H21NO3	3762	Moderate		Inter Info	[10], [1], [29]
D0908		Leuprolide	C59H84N16O12	657181	Moderate		Inter Info	[10], [1], [29]
D0992		Mefloquine	C17H16F6N2O	4046	Moderate		Inter Info	[10], [1], [29]
D1017		Methadone	C21H27NO	4095	Moderate		Inter Info	[10], [1], [29]
D1063		Mifepristone	C29H35NO2	55245	Moderate		Inter Info	[10], [1], [29]
D1075		Mirtazapine	C17H19N3	4205	Moderate		Inter Info	[10], [1], [29]
D1092		Moxifloxacin	C21H24FN3O4	152946	Moderate		Inter Info	[10], [1], [29]
D1137		Nilutamide	C12H10F3N3O4	4493	Moderate		Inter Info	[10], [1], [29]
D1158		Nortriptyline	C19H21N	4543	Moderate		Inter Info	[10], [1], [29]
D1181		Ondansetron	C18H19N3O	4595	Moderate		Inter Info	[10], [1], [29]
D1185		Orciprenaline	C11H17NO3	4086	Moderate		Inter Info	[10], [1], [42]
D1193		Oxaliplatin	C8H14N2O4Pt	9887053	Moderate		Inter Info	[10], [1], [29]
D1210		Oxytocin	C43H66N12O12S2	439302	Moderate		Inter Info	[10], [1], [29]
D1216		Palonosetron	C19H24N2O	6337614	Moderate		Inter Info	[10], [1], [29]
D1246		Pentamidine	C19H24N4O2	4735	Moderate		Inter Info	[10], [1], [29]
D1257		Perphenazine	C21H26ClN3OS	4748	Moderate		Inter Info	[10], [1], [29]
D1346		Prochlorperazine	C20H24ClN3S	4917	Moderate		Inter Info	[10], [1], [29]
D1351		Promazine	C17H20N2S	4926	Moderate		Inter Info	[10], [1], [29]
D1356		Propofol	C12H18O	4943	Moderate		Inter Info	[10], [1], [29]
D1371		Quinidine	C20H24N2O2	441074	Moderate		Inter Info	[10], [1], [29]
D1372		Quinine	C20H24N2O2	3034034	Moderate		Inter Info	[10], [1], [29]
D1383		Ranolazine	C24H33N3O4	56959	Moderate		Inter Info	[10], [1], [29]
D1413		Risperidone	C23H27FN4O2	5073	Moderate		Inter Info	[10], [1], [29]
D1414		Ritodrine	C17H21NO3	33572	Moderate		Inter Info	[10], [1], [29]
D1497		Sorafenib	C21H16ClF3N4O3	216239	Moderate		Inter Info	[10], [1], [29]
D1526		Tacrolimus	C44H69NO12	445643	Moderate		Inter Info	[10], [1], [29]
D1533		Tamoxifen	C26H29NO	2733526	Moderate		Inter Info	[10], [1], [29]
D1554		Terbutaline	C12H19NO3	5403	Moderate		Inter Info	[10], [1], [29]
D1555		Terfenadine	C32H41NO2	5405	Moderate		Inter Info	[10], [1], [29]
D1612		Toremifene	C26H28ClNO	3005573	Moderate		Inter Info	[10], [1], [29]
D1616		Tramadol	C16H25NO2	33741	Moderate		Inter Info	[10], [1], [29]
D1624		Trazodone	C19H22ClN5O	5533	Moderate		Inter Info	[10], [1], [29]
D1637		Trifluoperazine	C21H24F3N3S	5566	Moderate		Inter Info	[10], [1], [29]
D1638		Triflupromazine	C18H19F3N2S	5568	Moderate		Inter Info	[10], [1], [29]
D1647		Trimipramine	C20H26N2	5584	Moderate		Inter Info	[10], [1], [29]
D1682		Vardenafil	C23H32N6O4S	135400189	Moderate		Inter Info	[10], [1], [29]
D1683		Vasopressin	C46H65N15O12S2	644077	Moderate		Inter Info	[10], [1], [29]
D1689		Venlafaxine	C17H27NO2	5656	Moderate		Inter Info	[10], [1], [29]
D1726		Ziprasidone	C21H21ClN4OS	60854	Moderate		Inter Info	[10], [1], [29]
D1516		Sulfamethoxazole	C10H11N3O3S	5329	Minor		Inter Info	[34], [10], [1], [155], [156], [157], [158]
	Increased risk of ventricular arrhythmias					Drug Num: 7
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1211		Ozanimod	C23H24N4O3	52938427	Major		Inter Info	[12]
D0025		Adenosine	C10H13N5O4	60961	Moderate		Inter Info	[34], [35], [10], [1], [36], [37], [38], [39], [40], [41]
D0516		Donepezil	C24H29NO3	3152	Moderate		Inter Info	[34], [10], [1], [44], [45], [46]
D1418		Rivastigmine	C14H22N2O2	77991	Moderate		Inter Info	[34], [10], [1], [44], [45], [46]
D1569		Thalidomide	C13H10N2O4	5426	Moderate		Inter Info	[10], [1], [126]
D0707		Galantamine	C17H21NO3	9651	Moderate		Inter Info	[34], [10], [1], [44], [45], [46]
D1525		Tacrine	C13H14N2	1935	Moderate		Inter Info	[34], [10], [1], [44], [45], [46]

References
1	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
2	Drug interactions. Atazanavir and acid-reducing agents. TreatmentUpdate 18 (2006): 4. [PMID: 17209238]
3	Klein CE, Chiu YL, Cai Y, et al. "Effects of Acid-reducing agents on the pharmacokinetics of lopinavir/ritonavir and ritonavir-boosted atazanavir." J Clin Pharmacol 48 (2008): 553-62. [PMID: 18440920]
4	Product Information. Evotaz (atazanavir-cobicistat). Bristol-Myers Squibb, Princeton, NJ.
5	Product Information. Reyataz (atazanavir). Bristol-Myers Squibb, Princeton, NJ.
6	Ray JE, Marriott D, Bloch MT, McLachlan AJ "Therapeutic drug monitoring of atazanavir: surveillance of pharmacotherapy in the clinic." Br J Clin Pharmacol 60 (2005): 291-9. [PMID: 16120068]
7	Agarwala S, Persson A, Eley T, et al "Effect of famotidine 20 and 40 mg dosing regimens on the bioavailability of atazanavir with ritonavir in combination with tenofovir in healthy subjects".
8	Durant J, Clevenbergh P, Garraffo R, Halfon P, Icard S, DelGiudice P, Montagne N, Schapiro JM, Dellamonica P "Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt Study." Aids 14 (2000): 1333-9. [PMID: 10930147]
9	Product Information. Sprycel (dasatinib). Bristol-Myers Squibb, Princeton, NJ.
10	Cerner Multum, Inc. "Australian Product Information.".
11	Product Information. Nerlynx (neratinib). Puma Biotechnology, Inc., Los Angeles, CA.
12	Product Information. Zeposia (ozanimod). Celgene Corporation, Summit, NJ.
13	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
14	Product Information. Votrient (pazopanib). GlaxoSmithKline, Research Triangle Park, NC.
15	Tan AR, Gibbon DG, Stein MN, et al. "Effects of ketoconazole and esomeprazole on the pharmacokinetics of pazopanib in patients with solid tumors." Cancer Chemother Pharmacol 71 (2013): 1635-43. [PMID: 23636448]
16	van Leeuwen RW, van Gelder T, Mathijssen RH, Jansman FG "Drug-drug interactions with tyrosine-kinase inhibitors: a clinical perspective." Lancet Oncol 15 (2014): e315-e326. [PMID: 24988935]
17	Yu G, Zheng QS, Wang DX, Zhou HH, Li GF "Drug interactions between tyrosine-kinase inhibitors and acid suppressive agents: more than meets the eye." Lancet Oncol 15 (2014): e469-70. [PMID: 25281461]
18	Product Information. Edurant (rilpivirine). Tibotec Pharmaceuticals, Titusville, NJ.
19	Product Information. Retevmo (selpercatinib). Lilly, Eli and Company, Indianapolis, IN.
20	Product Information. Mayzent (siponimod). Novartis Pharmaceuticals, East Hanover, NJ.
21	Granfors MT, Backman JT, Laitila J, Neuvonen PJ "Tizanidine is mainly metabolized by cytochrome P450 1A2 in vitro." Br J Clin Pharmacol 57 (2004): 349-53. [PMID: 14998432]
22	Granfors MT, Backman JT, Neuvonen M, Ahonen J, Neuvonen PJ "Fluvoxamine drastically increases concentrations and effects of tizanidine: A potentially hazardous interaction." Clin Pharmacol Ther 75 (2004): 331-41. [PMID: 15060511]
23	Granfors MT, Backman JT, Neuvonen M, Neuvonen PJ "Ciprofloxacin greatly increases concentrations and hypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolism." Clin Pharmacol Ther 76 (2004): 598-606. [PMID: 15592331]
24	Momo K, Doki K, Hosono H, Homma M, Kohda Y "Drug interaction of tizanidine and fluvoxamine." Clin Pharmacol Ther 76 (2004): 509-10. [PMID: 15536467]
25	Momo K, Homma M, Kohda Y, Ohkoshi N, Yoshizawa T, Tamaoka A "Drug interaction of tizanidine and ciprofloxacin: Case report." Clin Pharmacol Ther 80 (2006): 717-9. [PMID: 17178273]
26	Product Information. Vioxx (rofecoxib). Merck & Co, Inc, West Point, PA.
27	Product Information. Zanaflex (tizanidine). Acorda Therapeutics, Hawthorne, NY.
28	Product Information. Zelboraf (vemurafenib). Genentech, South San Francisco, CA.
29	Product Information. Pepcid (famotidine). Merck & Co, Inc, West Point, PA.
30	Dey NG, Castleden CM, Ward J, et al "The effect of cimetidine on tolbutamide kinetics." Br J Clin Pharmacol 16 (1983): 438-40. [PMID: 6626438]
31	Feely J, Collins WCJ, Cullen CM, et al. "Potentiation of the hypoglycaemic response to glipizide in diabetic patients by histamine H2-receptor antagonists." Br J Clin Pharmacol 35 (1993): 321-3. [PMID: 8471413]
32	Kubacka RT, Antal EJ, Juhl RP "The paradoxical effect of cimetidine and ranitidine on glibenclamide pharmacokinetics and pharmacodynamics." Br J Clin Pharmacol 23 (1987): 743-51. [PMID: 3111514]
33	Lee K, Mize R, Lowenstein SR "Glyburide-induced hypoglycemia and ranitidine." Ann Intern Med 107 (1987): 261-2. [PMID: 3111324]
34	Canadian Pharmacists Association.
35	Celiker A, Tokel K, Cil E, Ozkutlu S, Ozme S "Adenosine induced torsades de pointes in a child with congenital long QT syndrome." Pacing Clin Electrophysiol 17 (1994): 1814-7. [PMID: 7838793]
36	Teodorovich N, Margolin E, Kogan Y, Paz O, Swissa M. Torsades de pointes after adenosine administration. J Electrocardiol. 2016;49(2):171-173. [PMID: 26850499]
37	Harrington GR, Froelich EG "Adenosine-induced torsades de pointes." Chest 103 (1993): 1299-1301. [PMID: 8131497]
38	Mallet ML "Proarrhythmic effects of adenosine: a review of the literature." Emerg Med J 21 (2004): 408-10. [PMID: 15208219]
39	Michalets EL, Williams CR "Drug interactions with cisapride: clinical implications." Clin Pharmacokinet 39 (2000): 49-75. [PMID: 10926350]
40	Tachakra SS, Robinson S "Adenosine and cardiac arrhythmias." BMJ 305 (1992): 422. [PMID: 1392935]
41	Wesley RC Jr, Turnquest P "Torsades de pointe after intravenous adenosine in the presence of prolonged QT syndrome." Am Heart J 123 (1992): 794-6. [PMID: 1539535]
42	Product Information. Pepcid (famotidine). Merck &amp Co, Inc, West Point, PA.
43	Product Information. Rescriptor (delavirdine). Pharmacia and Upjohn, Kalamazoo, MI.
44	Product Information. Aricept (donepezil). Pfizer US Pharmaceuticals, New York, NY.
45	Product Information. Exelon (rivastigmine) Novartis Pharmaceuticals, East Hanover, NJ.
46	Product Information. Razadyne (galantamine). Johnson and Johnson Medical Inc, Arlington, TX.
47	Product Information. Baraclude (entecavir). Bristol-Myers Squibb, Princeton, NJ.
48	Duong S, Leung M "Should the concomitant use of erlotinib and acid-reducing agents be avoided? The drug interaction between erlotinib and acid-reducing agents." J Oncol Pharm Pract 17 (2011): 448-52. [PMID: 20716581]
49	Product Information. Tarceva (erlotinib). Genentech, South San Francisco, CA.
50	Product Information. Calquence (acalabrutinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
51	Anderson JR, Poklis A, Slavin RG "A fatal case of theophylline intoxication." Arch Intern Med 143 (1983): 559-60. [PMID: 6830388]
52	Bachmann KA, Sullivan TJ, Jauregui L, Reese J, Miller K, Levine L "Drug interactions of h-2-receptor antagonists." Scand J Gastroenterol 29 (1994): 14-9. [PMID: 7863246]
53	Bauman JH, Kimelblatt BJ, Caraccio TR, Silverman HM, Simon GI, Beck GJ "Cimetidine-theophylline interaction: report of four patients." Ann Allergy 48 (1982): 100-2. [PMID: 6121526]
54	Boehning W "Effect of cimetidine and ranitidine on plasma theophylline in patients with chronic obstructive airways disease treated with theophylline and corticosteroids." Eur J Clin Pharmacol 38 (1990): 43-5. [PMID: 2328746]
55	Campbell MA, Plachetka JR, Jackson JE, Moon JF, Finley PR "Cimetidine decreases theophylline clearance." Ann Intern Med 95 (1981): 68-9. [PMID: 7247131]
56	Dal Negro R, Pomari C, Turco P "Famotidine and theophylline pharmacokinetics. An unexpected cimetidine-like interaction in patients with chronic obstructive pulmonary disease." Clin Pharmacokinet 24 (1993): 255-8. [PMID: 8462230]
57	Fenje PC, Isles AF, Baltodano A, MacLeod SM, Soldin S "Interaction of cimetidine and theophylline in two infants." Can Med Assoc J 126 (1982): 1178. [PMID: 7074441]
58	Fernandes E, Melewicz FM "Ranitidine and theophylline." Ann Intern Med 100 (1984): 459. [PMID: 6320702]
59	Hardman JG, Gilman AG, Limbird LE eds. "Goodman and Gilman's the Pharmacological Basis of Therapeutics. 9th ed." New York, NY: McGraw-Hill (1995):.
60	Hegman GW, Gilbert RP "Ranitidine-theophylline interaction--fact or fiction?" Ann Pharmacother 25 (1991): 21-5. [PMID: 2008782]
61	Hsu K, Garton A, Sproule BJ, Tam YK, Leggatt D, Herbert FA "The influence of orally administered cimetidine and theophylline on the elimination of each drug in patients with chronic airways obstruction." Am Rev Respir Dis 130 (1984): 740-3. [PMID: 6497156]
62	Jackson JE, Powell JR, Wandell M, Bentley J, Dorr R "Cimetidine decreases theophylline clearance." Am Rev Respir Dis 123 (1981): 615-7. [PMID: 7023306]
63	Kehoe WA, Sands CD, Long LF, et al "Effect of ranitidine on theophylline metabolism in healthy Koreans living in China." Ann Pharmacother 30 (1996): 133-7. [PMID: 8835044]
64	Kelly HW "Lack of evidence for reduction of theophylline clearance by ranitidine." Am J Med 86 (1989): 629-32. [PMID: 2712078]
65	Kelly HW, Powell JR, Donohue JF "Ranitidine at very large doses does not inhibit theophylline elimination." Clin Pharmacol Ther 39 (1986): 577-81. [PMID: 3698466]
66	Lin JH, Chremos AN, Chiou R, Yeh KC, Williams R "Comparative effect of famotidine and cimetidine on the pharmacokinetics of theophylline in normal volunteers." Br J Clin Pharmacol 24 (1987): 669-72. [PMID: 2893637]
67	Lofgren RP, Gilbertson RA "Cimetidine and theophylline." Ann Intern Med 96 (1982): 378. [PMID: 6800293]
68	Loi CM, Parker BM, Cusack BJ, Vestal RE "Aging and drug interactions .3. individual and combined effects of cimetidine and ciprofloxacin on theophylline metabolism in healthy male and female nonsmokers." J Pharmacol Exp Ther 280 (1997): 627-37. [PMID: 9023273]
69	Ohashi K, Sakamoto K, Sudo T, Tateishi T, Fujimura A, Shiga T, Ebihara A "Effects of diltiazem and cimetidine on theophylline oxidative metabolism." J Clin Pharmacol 33 (1993): 1233-7. [PMID: 8126258]
70	Powell JR, Rogers JF, Wargin WA, Cross RE, Eshelman FN "Inhibition of theophylline clearance by cimetidine but not ranitidine." Arch Intern Med 144 (1984): 484-6. [PMID: 6322709]
71	Pride M, Deamer RL "Over-the-counter cimetidine and theophylline interaction." Am Fam Physician 52 (1995): 2180. [PMID: 7484712]
72	Reitberg DP, Bernhard H, Schentag JJ "Alteration of theophylline clearance and half-life by cimetidine in normal volunteers." Ann Intern Med 95 (1981): 582-5. [PMID: 7294546]
73	Roy AK, Cuda MP, Levine RA "Induction of theophylline toxicity and inhibition of clearance rates by ranitidine." Am J Med 85 (1988): 525-7. [PMID: 3177399]
74	Schwartz JI, Bachmann KA, Bond LW, Mahajan VK "Impact of cimetidine on the pharmacokinetics of the theophylline." Clin Pharm 1 (1982): 534-8. [PMID: 7185539]
75	Skinner MH, Lenert L, Blaschke TF "Theophylline toxicity subsequent to ranitidine administration: a possible drug-drug interaction." Am J Med 86 (1989): 129-32. [PMID: 2910084]
76	Upton RA "Pharmacokinetic interactions between theophylline and other medication (Part II)." Clin Pharmacokinet 20 (1991): 135-50. [PMID: 1709398]
77	Verdiani P, Di Carlo S, Baronti A "Famotidine effects on theophylline pharmacokinetics in subjects affected by COPD: comparison with cimetidine and placebo." Chest 94 (1988): 807-10. [PMID: 3168576]
78	Weinberger MM, Smith G, Milavetz G, Hendeles L "Decreased clearance of theophylline due to cimetidine ." N Engl J Med 304 (1981): 672. [PMID: 7453751]
79	Bachmann K, Sullivan TJ, Reese JH, Jauregui L, Miller K, Scott M, Yeh KC, Stepanavage M, King JD, Schwartz J "Controlled study of the putative interaction between famotidine and theophylline in patients with chronic obstructive pulmonary disease." J Clin Pharmacol 35 (1995): 529-35. [PMID: 7657856]
80	Honig PK, Gillespie BK "Clinical significance of pharmacokinetic drug interactions with over-the-counter (OTC) drugs." Clin Pharmacokinet 35 (1998): 167-71. [PMID: 9784931]
81	Sommers DK, van Wyk M, Moncrieff J, Schoeman HS "Influence of food and reduced gastric acidity on the bioavailability of bacampicillin and cefuroxime axetil." Br J Clin Pharmacol 18 (1984): 535-9. [PMID: 6091711]
82	Product Information. Bosulif (bosutinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
83	Product Information. Alunbrig (brigatinib). Ariad Pharmaceuticals Inc, Cambridge, MA.
84	Product Information. Spectracef (cefditoren). TAP Pharmaceuticals Inc, Deerfield, IL.
85	Hughes GS, Heald DL, Barker KB, et al. "The effects of gastric pH and food on the pharmacokinetics of a new oral cephalosporin, cefpodoxime proxetil." Clin Pharmacol Ther 46 (1989): 674-85. [PMID: 2557183]
86	Saathoff N, Lode H, Neider K, et al "Pharmacokinetics of cefpodoxime and interactions with an antacid and an H2 receptor antagonist." Antimicrob Agents Chemother 36 (1992): 796-800. [PMID: 1354432]
87	Product Information. Zykadia (ceritinib). Novartis Pharmaceuticals, East Hanover, NJ.
88	Product Information. Aciphex (rabeprazole) Janssen Pharmaceuticals, Titusville, NJ.
89	Product Information. Dexilant (dexlansoprazole). Takeda Pharmaceuticals America, Lincolnshire, IL.
90	Product Information. Prevacid (lansoprazole). TAP Pharmaceuticals Inc, Deerfield, IL.
91	Product Information. Tafinlar (dabrafenib). GlaxoSmithKline, Research Triangle Park, NC.
92	Product Information. Zantac (ranitidine). Glaxo Wellcome, Research Triangle Park, NC.
93	Product Information. Vizimpro (dacomitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
94	Product Information. Gilenya (fingolimod). Novartis Pharmaceuticals, East Hanover, NJ.
95	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod).".
96	Product Information. Lexiva (fosamprenavir). GlaxoSmithKline, Research Triangle Park, NC.
97	Blum RA, D'Andrea DT, Florentino BM, et al "Increased gastric pH and the bioavailability of fluconazole and ketoconazole." Ann Intern Med 114 (1991): 755-7. [PMID: 2012358]
98	Katz HI "Drug interactions of the newer oral antifungal agents." Br J Dermatol 141 (1999): 26-32. [PMID: 10730911]
99	Lazar JD, Wilner KD "Drug interactions with fluconazole." Rev Infect Dis 12 Suppl 3 (1990): s327-33. [PMID: 2330488]
100	Product Information. Sporonox (itraconazole). Janssen Pharmaceutica, Titusville, NJ.
101	Product Information. Corlanor (ivabradine). Amgen USA, Thousand Oaks, CA.
102	Adachi M, Hinatsu Y, et.al "Improved dissolution and absorption of ketoconazole in the presence of organic acids as pH-modifiers." Eur J Pharm Sci 76 (2015): 225-30. [PMID: 25988287]
103	Carlson JA, Mann HJ, Canafax DM "Effect of pH on disintegration and dissolution of ketoconazole tablets." Am J Hosp Pharm 40 (1983): 1334-6. [PMID: 6310994]
104	Cerner Multum, Inc "ANVISA Bulario Eletrnico.".
105	Cerner Multum, Inc. "Canadian Product Information.".
106	Chin TWF, Loeb M, Fong IW "Effects of an acidic beverage (coca-cola) on absorption of ketoconazole." Antimicrob Agents Chemother 39 (1995): 1671-5. [PMID: 7486898]
107	Piscitelli SC, Goss TF, Wilton JH, D'Andrea DT, Goldstein H, Schentag JJ "Effects of ranitidine and sucralfate on ketoconazole bioavailability." Antimicrob Agents Chemother 35 (1991): 1765-71. [PMID: 1952845]
108	Product Information. Ketoconazole (ketoconazole). Mylan Pharmaceuticals Inc, Morgantown, WV.
109	Van der Meer JW, Keuning JJ "The influence of gastric acidity on the bio-availability of ketoconazole." J Antimicrob Chemother 6 (1980): 552-4. [PMID: 6253434]
110	Product Information. Tykerb (lapatinib). Novartis Pharmaceuticals, East Hanover, NJ.
111	Product Information. Reyvow (lasmiditan). Lilly, Eli and Company, Indianapolis, IN.
112	Product Information. Harvoni (ledipasvir-sofosbuvir). Gilead Sciences, Foster City, CA.
113	Product Information. Tasigna (nilotinib). Novartis Pharmaceuticals, East Hanover, NJ.
114	Product Information. Turalio (pexidartinib). Daiichi Sankyo, Inc., Parsippany, NJ.
115	Alffenaar JW, van Assen S, van der Werf TS, Kosterink JG, Uges DR "Omeprazole significantly reduces posaconazole serum trough level." Clin Infect Dis 48 (2009): 839. [PMID: 19220151]
116	Dolton MJ, Ray JE, Chen SC, Ng K, Pont L, McLachlan AJ "Multicenter study of posaconazole therapeutic drug monitoring: exposure-response and factors affecting concentration." Antimicrob Agents Chemother 56 (2012): 5503-10. [PMID: 22890761]
117	Krishna G, Abutarif M, Xuan F, Martinho M, Angulo D, Cornely OA "Pharmacokinetics of oral posaconazole in neutropenic patients receiving chemotherapy for acute myelogenous leukemia or myelodysplastic syndrome." Pharmacotherapy 28 (2008): 1223-32. [PMID: 18823218]
118	Krishna G, Moton A, Ma L, Medlock MM, McLeod J "The pharmacokinetics and absorption of posaconazole oral suspension under various gastric conditions in healthy volunteers." Antimicrob Agents Chemother 53 (2009): 958-66. [PMID: 19075045]
119	Neubauer WC, Engelhardt M, Konig A, et al. "Therapeutic drug monitoring of posaconazole in hematology patients: experience with a new high-performance liquid chromatography-based method." Antimicrob Agents Chemother 54 (2010): 4029-32. [PMID: 20547790]
120	Product Information. Noxafil (posaconazole). Schering-Plough Corporation, Kenilworth, NJ.
121	Shields RK, Clancy CJ, Vadnerkar A, et al "Posaconzaole serum concentrations among cardiothoracic transplant recipients: factors impacting trough levels and correlation with clinical response to therapy." Antimicrob Agents Chemother 55 (2011): 1308-11. [PMID: 21189337]
122	Vaes M, Hites M, Cotton F, et al. "Therapeutic drug monitoring of posaconazole in patients with acute myeloid leukemia or myelodysplasic syndrome." Antimicrob Agents Chemother 56 (2012): 6298-303. [PMID: 23027198]
123	Walravens J, Brouwers J, Spriet I, Tack J, Annaert P, Augustijns P "Effect of pH and Comedication on Gastrointestinal Absorption of Posaconazole: Monitoring of Intraluminal and Plasma Drug Concentrations." Clin Pharmacokinet 50 (2011): 725-34. [PMID: 21973269]
124	Krishna G, Moton A, Ma L, Malavade D, Medlock M, McLeod J "Effect of gastric pH, dosing regimen and prandial state, food and meal timing relative to dose, and gastro-intestinal motility on absorption and pharmacokinetics of the antifungal posaconazole." 18th European Congress of Clinical Microbiology and Infectious Diseases April (2008): 20.
125	Product Information. Rozerem (ramelteon). Takeda Pharmaceuticals America, Lincolnshire, IL.
126	Product Information. Thalomid (thalidomide). Celgene Corporation, Warren, NJ.
127	Product Information. Epclusa (sofosbuvir-velpatasvir). Gilead Sciences, Foster City, CA.
128	Product Information. Iressa (gefitinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
129	Product Information. Alimta (pemetrexed). Lilly, Eli and Company, Indianapolis, IN.
130	Bradford GS, Taylor CT "Omeprazole and vitamin B-12 deficiency." Ann Pharmacother 33 (1999): 641-3. [PMID: 10369631]
131	Dutta SK "Vitamin b-12 malabsorption and omeprazole therapy." J Am Coll Nutr 13 (1994): 544-5. [PMID: 7706583]
132	Lavy NW "Omeprazole and vitamin B12." Ann Intern Med 121 (1994): 74. [PMID: 8198354]
133	Marcuard SP, Albernaz L, Khazanie PG "Omeprazole therapy causes malabsorption of cyanocobalamin (vitamin-b12)." Ann Intern Med 120 (1994): 211-5. [PMID: 8273984]
134	Salom IL, Silvis SE, Doscherholmen A "Effect of cimetidine on the absorption of vitamin B12." Scand J Gastroenterol 17 (1982): 129-31. [PMID: 7134827]
135	Product Information. Cymbalta (duloxetine). Lilly, Eli and Company, Indianapolis, IN.
136	Lebsack ME, Nix D, Ryerson B, et al "Effect of gastric acidity on enoxacin absorption." Clin Pharmacol Ther 52 (1992): 252-6. [PMID: 1526081]
137	Misiak PM, Eldon MA, Toothaker RD, Sedman AJ "Effects of oral cimetidine or ranitidine on the pharmacokinetics of intravenous enoxacin." J Clin Pharmacol 33 (1993): 53-6. [PMID: 8429114]
138	Albin H, Vincon G, Begaud B, Bistue C, Perez P "Effect of aluminum phosphate on the bioavailability of ranitidine." Eur J Clin Pharmacol 32 (1987): 97-9. [PMID: 3582475]
139	Albin H, Vincon G, Demotes-Mainard F, et al "Effect of aluminium phosphate on the bioavailability of cimetidine and prednisolone." Eur J Clin Pharmacol 26 (1984): 271-3. [PMID: 6723769]
140	Barzaghi N, Gatti G, Crema F, Perucca E "Impaired bioavailability of famotidine given concurrently with a potent antacid." J Clin Pharmacol 29 (1989): 670-2. [PMID: 2569486]
141	Bodemar G, Norlander B, Walan A "Diminished absorption of cimetidine caused by antacids." Lancet 02/24/79 (1979): 444-5. [PMID: 84296]
142	Covington TR, Lawson LC, Young LL, eds. "Handbook of Nonprescription Drugs. 10th ed." Washington, DC: American Pharmaceutical Association (1993):.
143	Donn KH, Eshelman FN, Plachetka JR, et al "The effects of antacid and propantheline on the absorption of oral ranitidine." Pharmacotherapy 4 (1984): 89-92. [PMID: 6326064]
144	Lin JH, Chremos AN, Kanovsky SM, Schwartz S, Yeh KC, Kann J "Effects of antacids and food on absorption of famotidine." Br J Clin Pharmacol 24 (1987): 551-3. [PMID: 2891370]
145	Mihaly GW, Marino AT, Webster LK, Jones DB, Louis WJ, Smallwood RA "High dose of antacid (Mylanta II) reduces bioavailability of ranitidine." Br Med J 285 (1982): 998-9. [PMID: 6289961]
146	Russell WL, Lopez LM, Normann SA, et al "Effect of antacids on predicted steady-state cimetidine concentrations." Dig Dis Sci 29 (1984): 385-9. [PMID: 6714054]
147	Shelly DW, Doering PL, Russell WL, Guild RT, Lopez LM, Perrin J "Effect of concomitant antacid administration on plasma cimetidine concentrations during repetitive dosing." Drug Intell Clin Pharm 20 (1986): 792-5. [PMID: 3769772]
148	Steinberg WM, Lewis JH, Katz DM "Antacids inhibit absorption of cimetidine." N Engl J Med 307 (1982): 400-4. [PMID: 7088113]
149	Product Information. Inlyta (axitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
150	Product Information. Iclusig (ponatinib). Ariad Pharmaceuticals Inc, Cambridge, MA.
151	Product Information. Effient (prasugrel). Lilly, Eli and Company, Indianapolis, IN.
152	Small DS, Farid NA, Payne CD, et al. "Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel." J Clin Pharmacol 48 (2008): 475-84. [PMID: 18303127]
153	Inotsume N, Nishimura M, Nakano M, Fujiyama S, Sato T "The inhibitory effect of probenecid on renal excretion of famotidine in young, healthy volunteers." J Clin Pharmacol 30 (1990): 50-6. [PMID: 2303581]
154	Product Information. Isentress (raltegravir). Merck & Company Inc, West Point, PA.
155	Crouch MA, Limon L, Cassano AT "Clinical relevance and management of drug-related QT interval prolongation." Pharmacotherapy 23 (2003): 881-908. [PMID: 12885102]
156	Darpo B "Spectrum of drugs prolonging QT interval and the incidence of torsades de pointes." Eur Heart J Suppl 3(Suppl K) (2001): K70-80.
157	Lopez JA, Harold JG, Rosenthal MC, Oseran DS, Schapira JN, Peter T "QT prolongation and torsades de pointes after administration of trimethoprin-sulfamethoxazole." Am J Cardiol 59 (1987): 376-7. [PMID: 3492908]
158	Wiener I, Rubin D, Martinez E, et al "QT prolongation and paroxysmal ventricular tachycardia occurring during fever following trimethoprim-sulfamethoxazole administration." Mt Sinai J Med 48 (1981): 53-5. [PMID: 6970886]
159	Product Information. Erivedge (vismodegib). Genentech, South San Francisco, CA.

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence